Kelsi Smith, Senior Project Lead at Quantify Research, shared a post on LinkedIn:
“Day 1 of EHA done!
Had really interesting conversations with many people working in various indications. What did I learn today?
The Nordic data fits such a niche and can answer a lot of the questions needed to advance treatments in hematology. Access to detailed individual level laboratory data in addition to all the other registers like hosptial based care and surgeries, pharmacological treatments in and outside of hospital allow for detailed characterisation of multiple types of hemetological cancers and understanding endpoints. Early understanding of what evidence is needed to facilitate JCA processes and demonstrate value will be a race every company needs to address.
Did you know this about Nordic data?
Great day with Cathrine Tipsmark who understands the landscape, and great time representing Quantify Research as part of the athagoras Group. Looking forwards to day 2!”
Read other articles on OncoDaily.
